Michael Myers - 27 Jan 2025 SCHEDULE 13D/A Report for Quoin Pharmaceuticals Ltd. Ordinary Shares, no par value per share (represented by American Depositary Shares) (QNRX)

Filing Manager: Michael Myers
Reporting Manager: Michael Myers
Security: Quoin Pharmaceuticals Ltd. Ordinary Shares, no par value per share (represented by American Depositary Shares)
Symbol: QNRX
Shares outstanding: 19,167,959 shares
Disclosed Ownership: 939,230 shares
Ownership: 4.9%
Form type: SCHEDULE 13D/A
Filing time: 28 Jan 2025, 16:44:09 UTC
Date of event: 27 Jan 2025
Previous filing: 02 Jan 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Michael Myers	4.9%	939,230	939,230	0	/s/ Michael Myers	Dr. Michael Myers	0001959547